Status:
COMPLETED
Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair
Lead Sponsor:
Samsung Medical Center
Conditions:
Abdominal Aortic Aneurysms (AAA)
Endovascular Aneurysm Repair (EVAR)
Eligibility:
All Genders
18+ years
Brief Summary
This study was a target trial emulation using the National Health Claims database established by the Korean National Health Insurance Service (K-NHIS). 8,325 patients were included.
Detailed Description
Among these patients, any patients who were prescribed SAPT or DAPT at the date of discharge from the index hospitalization for standard EVAR were defined as being in the SAPT group (N=4,162) and the ...
Eligibility Criteria
Inclusion
- All patients who underwent EVAR for AAA and were successfully discharged
Exclusion
- Patients who had experienced a myocardial infarction
- Patients who had experienced a stroke
- Patients who had experienced percutaneous coronary intervention
- Patients who had history of peripheral disease
- Patients who had major bleeding event within 1 year of admission
- Those prescribed non-vitamin K antagonist oral anticoagulant or warfarin
- Patients who did not prescribe any antiplatelet therapy
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
8325 Patients enrolled
Trial Details
Trial ID
NCT06876727
Start Date
January 1 2003
End Date
September 30 2023
Last Update
March 14 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.